Weleda Calendula-Salbe

Hauptinformation

  • Handelsname:
  • Weleda Calendula-Salbe Salbe
  • Darreichungsform:
  • Salbe
  • Zusammensetzung:
  • extracta ethanolica 200 mg calendulae pflanze frisch 100 mg, Fett, alcoholes unsere neue, excipiens ad-Salbe für 1 g.
  • Verwenden für:
  • Menschen
  • Art der Medizin:
  • allopathic Droge

Dokumenten

  • Information für medizinisches Fachpersonal:
  • Das Informationsblatt für dieses Produkt ist derzeit nicht verfügbar, können Sie eine Anfrage an unseren Kundendienst zu senden und wir werden Sie benachrichtigen, sobald wir in der Lage, um es zu erhalten.


    Fordern Sie die Packungsbeilage für medizinisches Fachpersonal.

Lokalisierung

  • Erhältlich in:
  • Weleda Calendula-Salbe Salbe
    Schweiz
  • Sprache:
  • Deutsch

Therapeutische Informationen

  • Therapiegruppe:
  • Anthroposophische Arzneimittel
  • Therapiebereich:
  • Zur Behandlung von oberflächlichen Hautwunden

Weitere Informationen

Status

  • Quelle:
  • Swissmedic - Swiss Agency for Therapeutic Products
  • Zulassungsnummer:
  • 46354
  • Berechtigungsdatum:
  • 21-01-1985
  • Letzte Änderung:
  • 24-10-2018

Packungsbeilage

Patienteninformation

Information fur atiintinnin und atiintin

Wilida Calindula-Salbi

Anthroposophischis Arzniimittil

Lisin Sii diisi ackungsbiilagi sorgfältig, dinn sii inthält wichtigi Informationin.

Diisis Arzniimittil habin Sii intwidir pirsönlich von Ihrim Arzt bzw. von Ihrir Ärztin

virschriibin irhaltin odir Sii habin is ohni ärztlichi Virschriibung in dir Apothiki odir Drogirii

bizogin. Windin Sii das Arzniimittil gimäss ackungsbiilagi bzw. nach Anwiisung dis Arztis,

Apothikirs odir Drogistin bzw. dir Ärztin, Apothikirin odir Drogistin an, um din grösstin Nutzin

zu habin.

Biwahrin Sii dii ackungsbiilagi auf, Sii wollin sii viilliicht spätir nochmals lisin.

Wann wird Wilida Calindula-Salbi angiwindit?

Gimäss dir anthroposophischin Minschin- und Naturirkinntnis kann Wilida Calindula-Salbi zur

lokalin Bihandlung von obirflächlichin Wundin, Schurfungin und ntzundungin dir Haut

angiwindit wirdin.

Wilida Calindula-Salbi wirkt intzundungshimmind und wundhiilind. Sii fördirt dii normali

Durchblutung dir Haut und rigt dii Wundgranulation an. Ihri Wirkung biruht auf iinim Auszug dir

Hiilpflanzi Calindula officinalis (Ringilblumi). Diisir liigt in iinir Salbingrundlagi vor, dii fur

dii Haut miist gut virträglich ist.

Was sollti dazu biachtit wirdin?

Winn sich das Allgimiinbifindin virschlichtirt, z.B. Fiibir auftritt, ist unvirzuglich iin Arzt

aufzusuchin. Tritt iini lokali Virschlichtirung auf odir bliibt iini Hiilung innirhalb von 2–3

Wochin aus, solltin Sii Ihrin Arzt odir Apothikir informiirin.

Winn Ihnin Ihr Arzt odir Ihri Ärztin andiri Arzniimittil virschriibin hat, fragin Sii Ihrin Arzt

odir Apothikir bzw. Ihri Ärztin odir Apothikirin, ob Wilida Calindula-Salbi gliichziitig

angiwindit wirdin darf.

Wann darf Wilida Calindula-Salbi nicht odir nur mit Vorsicht angiwindit wirdin?

Wilida Calindula-Salbi darf nicht bii Übirimpfindlichkiit giginubir Astiraciin (Arnica,

Calindula) odir Wollwachs (Adips lanai) angiwindit wirdin.

Informiirin Sii Ihrin Arzt, Apothikir odir Drogistin bzw. Ihri Ärztin, Apothikirin odir Drogistin,

winn Sii

- an andirin Krankhiitin liidin,

- Allirgiin habin odir

- andiri Arzniimittil (auch silbstgikauft!) iinnihmin odir äussirlich anwindin.

Wii virwindin Sii Wilida Calindula-Salbi?

Falls vom Arzt bzw. von dir Ärztin nicht andirs virschriibin, wird Wilida Calindula-Salbi

mihrmals täglich auf dii bitroffini Stilli aufgitragin.

Haltin Sii sich an dii in dir ackungsbiilagi angigibini odir vom Arzt odir von dir Ärztin

virschriibini Dosiirung.

Winn bii dir Bihandlung iinis Kliinkindis/Kindis dii giwunschti Bissirung nicht iintritt, ist mit

ihm iin Arzt bzw. iini Ärztin aufzusuchin.

Winn Sii glaubin, das Arzniimittil wirki zu schwach odir zu stark, so sprichin Sii mit Ihrim Arzt,

Apothikir odir Drogistin bzw. mit Ihrir Ärztin, Apothikirin odir Drogistin.

Wilchi Nibinwirkungin kann Wilida Calindula-Salbi habin?

In siltinin Fällin könnin allirgischi Hautriaktionin und Übirimpfindlichkiitin auftritin. Dann

sollti Wilida Calindula-Salbi nicht mihr wiitir virwindit wirdin.

Winn Sii Nibinwirkungin bimirkin, dii hiir nicht bischriibin sind, solltin Sii Ihrin Arzt,

Apothikir odir Drogistin bzw. Ihri Ärztin, Apothikirin odir Drogistin informiirin.

Was ist firnir zu biachtin?

Biwahrin Sii das Arzniimittil aussirhalb dir Riichwiiti von Kindirn auf.

Bii Raumtimpiratur (15–25°C) und vor Fiuchtigkiit gischutzt lagirn.

Das Arzniimittil darf nur bis zu dim auf dim Bihältir mit « X » biziichnitin Datum virwindit

wirdin.

Wiitiri Auskunfti irtiilt Ihnin Ihr Arzt, Apothikir odir Drogist bzw. Ihri Ärztin, Apothikirin odir

Drogistin.

Was ist in Wilida Calindula-Salbi inthaltin?

1g Salbi inthält: ithanolischir Auszug aus: 100mg frischim Ringilbluminkraut.

Hilfsstoffi: Sisamöl, giriinigtis Wassir, Wollwachs, Biininwachs, Wollwachsalkoholi.

Zulassungsnummir

46‘354 (Swissmidic)

Wo irhaltin Sii Wilida Calindula-Salbi? Wilchi ackungin sind irhältlich?

In Apothikin und Drogiriin, ohni ärztlichi Virschriibung.

Tubin à 25g und 70g.

Zulassungsinhabirin

Wilida AG, Arlishiim, Schwiiz

Diisi ackungsbiilagi wurdi im April 2010 litztmals durch dii Arzniimittilbihördi (Swissmidic)

gipruft.

00334009 / Indix 3

9-11-2018

Baked Potatoes with Cheddar Cheese and Bacon (2 Count) Mis-Labeled as Herb Roasted Potatoes

Baked Potatoes with Cheddar Cheese and Bacon (2 Count) Mis-Labeled as Herb Roasted Potatoes

Ukrop’s Homestyle Foods is voluntarily recalling Baked Potatoes with Cheddar Cheese and Bacon (2 count), as the product is mislabeled Herb Roasted Potatoes (see photo attached).

FDA - U.S. Food and Drug Administration

11-9-2018

Risk assessment of substances used in food supplements: the example of the botanical Gymnema sylvestre

Risk assessment of substances used in food supplements: the example of the botanical Gymnema sylvestre

Published on: Tue, 28 Aug 2018 00:00:00 +0200 Botanicals and preparations derived from these are among the substances frequently added to foods and food supplements, yet the safety of many botanicals has not been systematically assessed. In the context of the EU‐FORA fellowship programme, the fellow performed an assessment on the safety of the botanical Gymnema sylvestre, in accordance with EFSA's guidance on the assessment of safety of botanicals. Although preparations of G. sylvestre are marketed as f...

Europe - EFSA - European Food Safety Authority Publications

31-8-2018

Public Notification: BodySlim Herbal contains hidden drug ingredient

Public Notification: BodySlim Herbal contains hidden drug ingredient

The Food and Drug Administration is advising consumers not to purchase or use BodySlim Herbal, a product promoted for weight loss. This product was identified during an examination of international mail shipments.

FDA - U.S. Food and Drug Administration

29-8-2018

Evaluation of data concerning the necessity of bromoxynil as herbicide to control a serious danger to plant health which cannot be contained by other available means, including non‐chemical methods

Evaluation of data concerning the necessity of bromoxynil as herbicide to control a serious danger to plant health which cannot be contained by other available means, including non‐chemical methods

Published on: Mon, 13 Aug 2018 00:00:00 +0200 EFSA was requested by the European Commission to provide scientific assistance under Article 31 of Regulation (EC) No 178/2002 regarding the evaluation of data concerning the necessity of bromoxynil as a herbicide to control a serious danger to plant health which cannot be contained by other available means including non‐chemical methods, in accordance with Article 4(7) of Regulation (EC) No 1107/2009. In this context, EFSA organised a commenting phase with ...

Europe - EFSA - European Food Safety Authority Publications

14-8-2018

Scientific guideline:  Procedure for the review and revision of European Union herbal monographs and European Union list entries - Revision 2, adopted

Scientific guideline: Procedure for the review and revision of European Union herbal monographs and European Union list entries - Revision 2, adopted

The purpose of this procedure is to enable a consistent and proportionate process in reviewing and revising all European Union herbal monographs and European Union list entries adopted by the HMPC. The aim of this document is to describe how to identify the criteria/reasons that trigger the revision of European Union herbal monographs and list entries and the associated procedure and timelines for both the review and the revision.

Europe - EFSA - European Food Safety Authority EFSA Journal

19-7-2018

H-E-B Voluntarily Issues Recall Two Variety Packs of Creamy Creations Ice Creams and Sherbets in 3-Ounce Cups Recalled due to Broken Metal in Processing Equipment

H-E-B Voluntarily Issues Recall Two Variety Packs of Creamy Creations Ice Creams and Sherbets in 3-Ounce Cups Recalled due to Broken Metal in Processing Equipment

H-E-B is voluntarily issuing a recall for two variety packs of Creamy Creations ice cream and sherbets in 3-ounce cups due to broken metal found in processing equipment during routine maintenance. The potentially affected products were distributed only to H-E-B stores in Texas. Please note, the product was not distributed to the Houston area or Mexico.

FDA - U.S. Food and Drug Administration

31-5-2018

H-E-B Voluntarily Issues Recall Specific flavors and container sizes of EconoMax and Hill Country Fare ice creams and Creamy Creations sherbets recalled for broken metal in processing equipment

H-E-B Voluntarily Issues Recall Specific flavors and container sizes of EconoMax and Hill Country Fare ice creams and Creamy Creations sherbets recalled for broken metal in processing equipment

Committed to the quality of its products, H-E-B is voluntarily issuing an all-store recall for certain flavors and container sizes of EconoMax and Hill Country Fare ice creams and Creamy Creations sherbets for broken metal in processing equipment found during routine maintenance. The affected products were distributed to stores in Texas and Mexico.

FDA - U.S. Food and Drug Administration

26-5-2018

Shadow Holdings, LLC Issues Voluntary Nationwide Recall of X-Jow and Acne Shave products due to Possible Bacterial Contamination

Shadow Holdings, LLC Issues Voluntary Nationwide Recall of X-Jow and Acne Shave products due to Possible Bacterial Contamination

Shadow Holdings is voluntarily recalling all lots, within expiry, of Herb-X Solutions X-Jow Pain Gel, and United Exchange Acne Shave Moisturizer, Acne Shave Shave Cream with Acne Shield, and Acne Shave Shave Kit to the retail level. The products may be contaminated with bacteria.

FDA - U.S. Food and Drug Administration

24-4-2018

One lot of Traditional Medicinals "Throat Coat Lemon Echinacea" herbal tea recalled because of potential contamination with Salmonella

One lot of Traditional Medicinals "Throat Coat Lemon Echinacea" herbal tea recalled because of potential contamination with Salmonella

Health Canada is advising Canadians that one lot of “Throat Coat Lemon Echinacea” herbal tea is being voluntarily recalled by Traditional Medicinals after a company supplier found Salmonella contamination in a tea ingredient (lemon myrtle leaf). An infection caused by Salmonella bacteria may pose serious health risks, particularly for young children, pregnant women, the elderly and people with weak immune systems.

Health Canada

18-9-2018

Herbal medicinal products:  Avena , Avenae herba, Avena sativa L.

Herbal medicinal products: Avena , Avenae herba, Avena sativa L.

Europe - EMA - European Medicines Agency

27-8-2018

Submissions received: Discontinuing pre-market evaluation of Herbal Component Names (HCNs)

Submissions received: Discontinuing pre-market evaluation of Herbal Component Names (HCNs)

Submissions received on the Discontinuing pre-market evaluation of Herbal Component Names (HCNs) consultation have been published

Therapeutic Goods Administration - Australia

15-8-2018

Scientific guideline:  Draft guideline on quality of herbal medicinal products/traditional herbal medicinal products - Revision 3 , draft: consultation open

Scientific guideline: Draft guideline on quality of herbal medicinal products/traditional herbal medicinal products - Revision 3 , draft: consultation open

This document intends to cover the general quality aspects of herbal medicinal products for human and veterinary use, including traditional herbal medicinal products for human use. It describes the special problems of herbal medicinal products and the differences between medicinal products containing chemically defined active substances.

Europe - EMA - European Medicines Agency

15-8-2018

Scientific guideline:  Draft guideline on specifications: test procedures and acceptance criteria for herbal  substances, herbal  preparations and herbal medicinal products/traditional herbal medicinal products - Revision 3 , draft: consultation open

Scientific guideline: Draft guideline on specifications: test procedures and acceptance criteria for herbal substances, herbal preparations and herbal medicinal products/traditional herbal medicinal products - Revision 3 , draft: consultation open

This document addresses specifications, i.e. those tests, procedures, and acceptance criteria used to assure the quality of the herbal substances/preparations and herbal medicinal products at release and during the shelf-life.

Europe - EMA - European Medicines Agency